Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.61 |
| ▸ | BRD4 | O60885 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 5/20 | 0.41 |
| ▸ | RAB9A | P51151 | 5/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13415305 | 0.84 | ACHE (0.80) | ACHELMNATHRBMAPTTP53 | |
| SCHEMBL3456771 | 0.81 | NPC1 (0.66) | BRD4LMNATHRBMAPTTP53 | |
| SCHEMBL6702382 | 0.80 | BRD4 (0.56) | ACHEBRD4LMNATHRBMAPT | |
| SCHEMBL29569624 | 0.80 | BRD4 (0.56) | ACHEBRD4LMNATHRBMAPT | |
| SCHEMBL5952948 | 0.79 | ACHE (0.71) | ACHELMNATHRBMAPTTP53 | |
| SCHEMBL3858388 | 0.77 | ACHE (0.69) | ACHELMNATHRBMAPTTP53 | |
| SCHEMBL21850851 | 0.77 | CNR2 (0.40) | ACHEBRD4LMNATHRBMAPT | |
| SCHEMBL400963 | 0.76 | ACHE (0.67) | ACHELMNATHRBMAPTTP53 | |
| SCHEMBL2645654 | 0.76 | ACHE (0.67) | ACHELMNATHRBMAPTTP53 | |
| SCHEMBL2310534 | 0.76 | ACHE (0.67) | ACHELMNATHRBMAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116940562-A | Acetamido-phenylbenzamide derivatives and methods of use thereof | 希华医药有限公司 | 2023-10-24 | — | — | CN | disclosed |
| EP-4225745-A1 | ACETAMIDO-PHENYLBENZAMIDE DERIVATIVES AND METHODS OF USING THE SAME | Athenex, Inc. (US) | 2023-08-16 | — | — | EP | disclosed |
| US-20220227765-A1 | PYRIDO-INDOLE ANALOGUES AS GPX4 INHIBITORS | ADRENAS THERAPEUTICS INC. | 2022-07-21 | — | — | US | disclosed |
| WO-2022076662-A1 | ACETAMIDO-PHENYLBENZAMIDE DERIVATIVES AND METHODS OF USING THE SAME | ATHENEX, INC. (US) | 2022-04-14 | — | — | WO | disclosed |
| US-20220106301-A1 | ACETAMIDO-PHENYLBENZAMIDE DERIVATIVES AND METHODS OF USING THE SAME | Health Hope Pharma Limited (HK) | 2022-04-07 | — | — | US | disclosed |
| WO-2021041539-A2 | COMPOUNDS AND METHODS OF USE | Ferro Therapeutics, Inc. (US) | 2021-03-04 | — | — | WO | disclosed |
| WO-2021041539-A2 | COMPOUNDS AND METHODS OF USE | Ferro Therapeutics, Inc. (US) | 2021-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220106301-A1 | ACETAMIDO-PHENYLBENZAMIDE DERIVATIVES AND METHODS OF USING THE SAME | ABCB1, ABCC1, UGT2B7 | ACHE 1867/4885BRD4 3982/4885LMNA 3155/4885 |
| US-20220227765-A1 | PYRIDO-INDOLE ANALOGUES AS GPX4 INHIBITORS | GPX4, GPX1, AIFM2 | ACHE 3752/4885BRD4 116/4885LMNA 4607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.